These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22475612)

  • 1. Low-dose interleukin-2 and HCV-induced vasculitis.
    Oo YH; Mutimer D; Adams DH
    N Engl J Med; 2012 Apr; 366(14):1353-4; author reply 1354. PubMed ID: 22475612
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
    Saadoun D; Rosenzwajg M; Joly F; Six A; Carrat F; Thibault V; Sene D; Cacoub P; Klatzmann D
    N Engl J Med; 2011 Dec; 365(22):2067-77. PubMed ID: 22129253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The yin and yang of interleukin-2-mediated immunotherapy.
    Bluestone JA
    N Engl J Med; 2011 Dec; 365(22):2129-31. PubMed ID: 22129258
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
    Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
    Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A delicate balance: tweaking IL-2 immunotherapy.
    Nat Med; 2012 Feb; 18(2):208-9. PubMed ID: 22310686
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
    Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
    J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Sene D; Limal N; Piette JC
    J Rheumatol; 2005 Nov; 32(11):2078-82. PubMed ID: 16265682
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of necrotizing vasculitic lesions after infusion of iloprost in a patient with cryoglobulinemia and chronic HCV infection.
    Lo Gullo R; De Filippis L; Caliri A; Bagnato G
    Clin Exp Rheumatol; 2005; 23(6):912-3. PubMed ID: 16396716
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.
    Lamprecht P; Moosig F; Gause A; Herlyn K; Csernok E; Hansen H; Gross WL
    Ann Rheum Dis; 2001 Apr; 60(4):385-90. PubMed ID: 11247870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
    Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
    Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful rituximab therapy of HCV-cryoglobulinemic vasculitis with severe ulcerative and necrotic lesions of the skin].
    Ignatova TM; Chernova OA; Gaĭdasheva EV
    Klin Med (Mosk); 2012; 90(5):64-6. PubMed ID: 22993956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
    Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
    Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
    Basile U; Gragnani L; Piluso A; Gulli F; Urraro T; Dell'Abate MT; Torti E; Stasi C; Monti M; Rapaccini GL; Zignego AL
    Liver Int; 2015 Sep; 35(9):2100-7. PubMed ID: 25800731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
    Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
    Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vasculitis with undetectable cryoglobulinemia in chronic hepatitis C.
    Martins Junior EV; Gaburri AK; Gaburri PD; Chebli JM
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1220-1. PubMed ID: 15377307
    [No Abstract]   [Full Text] [Related]  

  • 17. The place of immunotherapy in the management of HCV-induced vasculitis: an update.
    Chiche L; Bataille S; Kaplanski G; Jourde N
    Clin Dev Immunol; 2012; 2012():315167. PubMed ID: 22927871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
    J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
    Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
    Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urticarial vasculitis with asymptomatic chronic hepatitis C infection: response to doxepin, interferon-alfa, and ribavirin.
    Kelkar PS; Butterfield JH; Kalaaji AN
    J Clin Gastroenterol; 2002 Sep; 35(3):281-2. PubMed ID: 12192209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.